Glenmark Pharmaceuticals Reports - Industry Research

Reports Featuring Glenmark Pharmaceuticals

Carbonated Beverages Market Major Players

Meglitinide Market

The Meglitinide Market size is estimated at USD 4.35 billion in 2024, and is expected to reach USD 4.85 billion by 2029, growing at a CAGR of 2.21% during the forecast period (2024-2029).

North America Biguanide Market

The North America Biguanide Market size is estimated at USD 1.36 billion in 2024, and is expected to reach USD 1.58 billion by 2029, growing at a CAGR of 2.59% during the forecast period (2024-2029).

Tinea Pedis Treatment Market

The Tinea Pedis Treatment Market size is estimated at USD 1.38 billion in 2024, and is expected to reach USD 1.69 billion by 2029, growing at a CAGR of 4.19% during the forecast period (2024-2029).

North America Alpha-Glucosidase Inhibitors Market

The North America Alpha-Glucosidase Inhibitors Market size is estimated at USD 0.28 billion in 2024, and is expected to reach USD 0.32 billion by 2029, growing at a CAGR of 2.5% during the forecast period (2024-2029).

Dextromethorphan Market

The dextromethorphan market is expected to register a CAGR of 4.1% over the forecast period.

Anti-fungal Drugs Market

The anti-fungal drugs market is expected to register a CAGR of 3.5% during the forecast period.

Progesterone Market

The progesterone market is expected to record a CAGR of 13.1% over the forecast period.

Global Anti Malarial Drugs Market

The Anti Malarial Drugs market is expected to register a CAGR of 3.7% over the forecast period (2022-2027).

Primary Biliary Cholangitis (PBC) Therapeutics Market

The global primary biliary cholangitis (PBC) market is projected to grow with a CAGR of nearly 10% over the forecast period.

Herpes Simplex Virus Treatment Market

The Herpes Simplex Virus Treatment Market size is estimated at USD 2.48 billion in 2024, and is expected to reach USD 3.13 billion by 2029, growing at a CAGR of 4.77% during the forecast period (2024-2029).

Global Tacrolimus Market

The tacrolimus market is expected to register a CAGR of 5.2% over the forecast period, 2022-2027.

Biguanides Market

The Biguanides Market size is estimated at USD 5.20 billion in 2024, and is expected to reach USD 5.76 billion by 2029, growing at a CAGR of 2.07% during the forecast period (2024-2029).

Cryptococcosis Therapeutics Market

Cryptococcosis is a fungal infection which is caused by Cryptococcus neoformans and Cryptococcus gattii which primarily affects the central nervous system and the lungs.

Global Fungal Keratitis Treatment Market

The Global Fungal Keratitis Treatment Market size is estimated at USD 0.86 billion in 2024, and is expected to reach USD 1.07 billion by 2029, growing at a CAGR of 4.60% during the forecast period (2024-2029).

Middle East and Africa Biguanide Market

The Middle East and Africa Biguanide Market size is estimated at USD 311.96 million in 2024, and is expected to reach USD 370.86 million by 2029, growing at a CAGR of 3.52% during the forecast period (2024-2029).

Triamcinolone Ointment Chlorofluorocarbons Market

Skin disease is one of the leading causes of the increasing global disease burden, affecting millions of people worldwide.

APAC Biguanide Market

The APAC Biguanide Market size is estimated at USD 1.97 billion in 2024, and is expected to reach USD 2.17 billion by 2029, growing at a CAGR of 2% during the forecast period (2024-2029).

Latin America Biguanide Market

The Latin America Biguanide Market size is estimated at USD 386.66 million in 2024, and is expected to reach USD 443.91 million by 2029, growing at a CAGR of 2.80% during the forecast period (2024-2029).

Latin America Meglitinide Market

The Latin America Meglitinide Market size is estimated at USD 0.22 billion in current year, and is expected to reach USD 0.26 million by forecast year, growing at a CAGR of 3.30% during the forecast period.

Europe Meglitinide Market

The Europe Meglitinide Market size is estimated at USD 1.08 billion in current year, and is expected to reach USD 1.21 billion by forecast year, growing at a CAGR of 2.30% during the forecast period.

North America Meglitinide Market

The North America Meglitinide Market size is expected to grow from USD 0.98 billion in current year to USD 1.05 billion by forecat year, at a CAGR of 1.50% during the forecast period.

APAC Meglitinide Market

The Asia-Pacific Meglitinide Market size is estimated at USD 1.62 billion in current year, and is expected to reach USD 1.76 billion by forecat year, growing at a CAGR of 1.70% during the forecast period.

Middle East And Africa Meglitinide Market

The Middle-East and Africa Meglitinide Market size is estimated at USD 0.2 billion in current year, and is expected to reach USD 0.3 billion by forecast year, growing at a CAGR of 4% during the forecast period.

Europe Alpha-Glucosidase Inhibitors Market

The Europe Alpha-Glucosidase Inhibitors Market size is expected to reach USD 1 billion over the forecast year, growing at a CAGR of 2.20% during the forecast period.

Latin America Alpha-Glucosidase Inhibitors Market

The Latin America Alpha-Glucosidase Inhibitors Market size is expected to grow from USD 72.47 million in current year to USD 85.24 million by forecast year, at a CAGR of 3.30% during the forecast period.

Middle East and Africa Alpha-Glucosidase Inhibitors Market

The Middle-East and Africa Alpha-Glucosidase Inhibitors Market size is estimated at USD 57.37 million in current year, and is expected to reach USD 68.46 million by forecast year, growing at a CAGR of 3.60% during the forecast period.

Asia-Pacific Alpha-Glucosidase Inhibitors Market

The Asia-Pacific Alpha-Glucosidase Inhibitors Market size is estimated at USD 4.14 billion in current year, and is expected to reach USD 4.64 billion by forecast year, growing at a CAGR of 2.30% during the forecast period.